title: The great escape: microbiotal LPS takes a toll on the liver.
abstract: The interaction between the intestinal microbiota and host is much more complex than previously appreciated, and we are now learning that it can have an impact on extraintestinal human diseases. In this issue of the journal (beginning on page 1090), Lin and colleagues present important data linking the microbiota, lipopolysaccharide (LPS), and toll-like receptor (TLR)4 with hepatitis in a mouse model. These provocative results and those from other recent studies highlight the microbiota as a potential target for therapeutic intervention in several liver diseases.
authors.affiliation: Emory Vaccine Center, Emory University, 954 Gatewood Road, Room 2028, Atlanta, GA 30329, USA. david.weiss@emory.edu
authors.forename: David S
authors.initials: DS
authors.lastname: Weiss
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D006505:Hepatitis / Q000276:immunology*; D008070:Lipopolysaccharides / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology*; D008297:Male; D051197:Toll-Like Receptor 4 / Q000276:immunology*
chemical_list: D008070:Lipopolysaccharides; C493487:Tlr4 protein, mouse; D051197:Toll-Like Receptor 4